| 000 | 00816 a2200241 4500 | ||
|---|---|---|---|
| 005 | 20250517115009.0 | ||
| 264 | 0 | _c20180827 | |
| 008 | 201808s 0 0 eng d | ||
| 022 | _a1759-4820 | ||
| 024 | 7 |
_a10.1038/nrurol.2016.183 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSidaway, Peter | |
| 245 | 0 | 0 |
_aProstate cancer: HSD3B1 variant confers inferior ADT outcomes. _h[electronic resource] |
| 260 |
_bNature reviews. Urology _c11 2016 |
||
| 300 |
_a632 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Comment | ||
| 650 | 0 | 4 | _aAndrogen Antagonists |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aProstatic Neoplasms |
| 773 | 0 |
_tNature reviews. Urology _gvol. 13 _gno. 11 _gp. 632 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/nrurol.2016.183 _zAvailable from publisher's website |
| 999 |
_c26432419 _d26432419 |
||